Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

In December, it became the first FDA-approved drug for the treatment of obstructive sleep apnea. Because it is approved to ...

Zepbound (tirzepatide) is a prescription drug that’s used for weight loss and obstructive ... Zepbound is also prescribed to treat moderate to severe obstructive sleep apnea in adults with ...

Novo Nordisk announced it is making the popular weight loss medication available to three telehealth companies and revealed plans to make it more affordable for those paying out-of-pocket.

People with mild sleep apnea may ... in treating obstructive sleep apnea. Some steps that a person can take to lose weight include: In addition to lifestyle changes that promote weight loss ...

As more doctors and patients turn to the latest weight-loss ... drugs can reduce the risk of liver and kidney symptoms as well. And Zepbound is approved to reduce the risk of obstructive sleep ...

Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.

According to The New York Times, the most popular of the drugs ... approved to treat sleep apnea, Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss.